|
Market Closed -
Nasdaq
21:00:00 06/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 36.31 USD | -2.44% |
|
-16.26% | +10.94% |
| 10-01 | Truist Cuts Price Target on Axogen to $53 From $60, Keeps Buy Rating | MT |
| 09-30 | Axogen, Inc. completed its acquisition of BioCircuit Technologies, Inc. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXOGEN, INC. | Other Advanced Medical Equipment & Technology | -2.44% | -16.26% | +10.94% | +103.08% | +136.70% | 2.18B |  |  |  |
- Stock Market
- Stocks
- AXGN Stock
- Charts Axogen, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
